Phase I and pharmacokinetics studies of prochlorperazine 2-h i.v. infusion as a doxorubicin-efflux blocker

K. S. Sridhar, A. Krishan, T. S.A. Samy, R. C. Duncan, A. Sauerteig, G. V. McPhee, M. E. Auguste, P. W. Benedetto

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint Dive into the research topics of 'Phase I and pharmacokinetics studies of prochlorperazine 2-h i.v. infusion as a doxorubicin-efflux blocker'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences